One-Year Outcomes Following Directional Atherectomy of Infrapopliteal Artery Lesions
Authors:
- Aljoscha RastanARAljoscha Rastan
- on behalf of the DEFINITIVE LE InvestigatorsOIon behalf of the DEFINITIVE LE Investigators
- 7 October 2015
- journal article
- research article
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 22 (6) , 839-846
Abstract
Purpose: To report a subgroup analysis of the prospective, multicenter, single-arm DEFINITIVE LE trial to assess the effectiveness of directional atherectomy for the treatment of infrapopliteal artery lesions at 1 year. Methods: In the DEFINITIVE LE trial, follow-up assessments occurred up to 1 year postprocedure. Of the 800 patients enrolled, 145 subjects with 189 infrapopliteal lesions met the criteria for this analysis. Seventy (48.3%) and 75 (51.7%) patients were suffering critical limb ischemia (CLI) and intermittent claudication, respectively; 68.3% (99/145) had diabetes. The mean lesion length was 58±44 mm (all lesions); 20.2% were occluded. The primary endpoint for patients with claudication was duplex ultrasound–derived primary patency, while for subjects with CLI it was freedom from major amputation of the target limb at 1 year. Endpoints and adverse events were independently assessed. Results: Procedure success (≤30% residual stenosis) was achieved in 84% of treated lesions. The 1-year primary patency rate was 84% (claudicants 89.6% and CLI patients 78%, p=0.11), and the freedom from major amputation rate was 97.1% (claudicants 100% and CLI 93.8%, p=0.03). In both claudication and CLI patients, significant improvements in Rutherford category and objective measures of walking distance and quality of life were seen at 1 year in comparison to baseline. Conclusion: This study demonstrates that directional atherectomy in infrapopliteal arteries results in promising technical and clinical results at 1 year for claudicant as well as CLI patients.Keywords
This publication has 11 references indexed in Scilit:
- Lower Extremity Revascularization Using Directional AtherectomyJACC: Cardiovascular Interventions, 2014
- Drug-Eluting Balloon in Peripheral Intervention for Below the Knee Angioplasty Evaluation (DEBATE-BTK)Circulation, 2013
- Management of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations)JACC, 2013
- A Prospective Randomized Multicenter Comparison of Balloon Angioplasty and Infrapopliteal Stenting With the Sirolimus-Eluting Stent in Patients With Ischemic Peripheral Arterial DiseaseJACC, 2012
- Sirolimus-Eluting Stents for Treatment of Infrapopliteal Arteries Reduce Clinical Event Rate Compared to Bare-Metal StentsJACC, 2012
- Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trialEuropean Heart Journal, 2011
- Infragenicular Stent Implantation for Below-the-Knee Atherosclerotic Disease: Clinical Evidence From an International Collaborative Meta-Analysis on 640 PatientsJournal of Endovascular Therapy, 2009
- Sirolimus-Eluting versus Bare Stents after Suboptimal Infrapopliteal Angioplasty for Critical Limb Ischemia: Enduring 1-Year Angiographic and Clinical BenefitJournal of Endovascular Therapy, 2007
- Two-Year Results after Directional Atherectomy of Infrapopliteal Arteries with the SilverHawk DeviceJournal of Endovascular Therapy, 2007
- Midterm Outcomes From the TALON Registry:Treating Peripherals With SilverHawk:Outcomes CollectionJournal of Endovascular Therapy, 2006